Skip to content
The Policy VaultThe Policy Vault

SogroyaMedica

growth disorders as defined in the standard Growth Disorders – Sogroya Prior Authorization Policy (Basic Formulary)

Preferred products

  • Ngenla
  • Skytrofa

Initial criteria

  • Patient meets the standard Growth Disorders – Sogroya Prior Authorization Policy criteria
  • AND patient meets ONE of the following:
  • • has tried ONE of Ngenla or Skytrofa for 6 months; OR
  • • has experienced an intolerance with Ngenla or Skytrofa

Approval duration

1 year